Founders

Gregory T. Baxter
Chief Scientific Officer

Dr. Baxter is the principal inventor of HµREL’s technology. Previously he was a Senior Scientist at the Cornell Nanofabrication Facility, Cornell University, and Cornell's Biology Liaison for the National Nanofabrication Users’ Network. He holds an Adjunct Professorship in the School of Chemical Engineering at Cornell, and has over ten years’ industrial experience in in vitro assay development, with an emphasis on the design and implementation of microfluidic-based, high-throughput automated assays for applications in drug discovery. Dr. Baxter has multidisciplinary research experience in cell biology, biochemistry, and cancer biology, and technical expertise in micro- and nanofabrication engineering. He has published over twenty peer-reviewed papers and book chapters, has served as principal investigator on a number of grants in the emerging field of nanobiotechnology, and is inventor or co-inventor on five U.S. patents or patent applications. Dr. Baxter also has experience in clinical drug development with extensive knowledge of FDA regulations including IND and NDA submissions. He received his Ph.D. in Biochemistry and Molecular Biology from the University of California, Santa Barbara, did his postdoctoral training in the Department of Cancer and Developmental Biology of Syntex Research, and served as a Senior Scientist at Molecular Devices Corporation.

email: gbaxter@hurelcorp.com